Wilson Sonsini Goodrich & Rosati advised Neurona Therapeutics on the transaction.Neurona Therapeutics announced it closed a $120 million financing co-led by Viking Global Investors and Cormorant Asset…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
